Selvita Group reports a dynamic increase in revenues for Q3 2021 YTD

KRAKOW, Poland, Nov. 24, 2021 /PRNewswire/ -- Selvita (WSE: SLV) – one of the largest preclinical contract research organizations in Europe continues its dynamic development. Following the acquisition of Fidelta, Selvita Group achieved in the three quarters of 2021 over a two-fold...